The Many Faces of Myxopapillary Ependymomas

References

1. 1.↵
   1. Bates JE,
   2. Choi G,
   3. Milano MT

   . Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes. J Neurooncol 2016;129:251–58 doi:10.1007/s11060-016-2167-0 pmid:27306443

   CrossRefPubMed
2. 2.↵
   1. Weber DC,
   2. Wang Y,
   3. Miller R, et al

   . Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol 2015;17:588–95 doi:10.1093/neuonc/nou293 pmid:25301811

   CrossRefPubMed
3. 3.↵
   1. Fassett DR,
   2. Pingree J,
   3. Kestle JR

   . The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature. J Neurosurg 2005;102:59–64 doi:10.3171/ped.2005.102.1.0059 pmid:16206735

   CrossRefPubMed
4. 4.↵
   1. Straus D,
   2. Tan LA,
   3. Takagi I, et al

   . Disseminated spinal myxopapillary ependymoma in an adult at initial presentation: a case report and review of the literature. Br J Neurosurg 2014;28:691–93 doi:10.3109/02688697.2014.881464 pmid:24460084

   CrossRefPubMed
5. 5.↵
   1. Louis DN,
   2. Ohgaki H,
   3. Wiestler OD

   , et al. World Health Organization Classification of Tumours of the Nervous System, 5th ed. International Agency for Research on Cancer 2016:104–06
6. 6.↵
   1. Pesce A,
   2. Palmieri M,
   3. Armocida D, et al

   . Spinal myxopapillary ependymoma: the Sapienza University experience and comprehensive literature review concerning the clinical course of 1602 patients. World Neurosurg 2019;129:245–53 doi:10.1016/j.wneu.2019.05.206 pmid:31152881

   CrossRefPubMed
7. 7.↵
   WHO Classification of Tumours Editorial Board. World Health Organization Classification of Tumours of the Central Nervous System, 5th ed. International Agency for Research on Cancer 2021:183–85
8. 8.↵
   1. Liu T,
   2. Yang C,
   3. Deng X, et al

   . Clinical characteristics and surgical outcomes of spinal myxopapillary ependymomas. Neurosurg Rev 2020;43:1351–56 doi:10.1007/s10143-019-01150-z pmid:31473875

   CrossRefPubMed
9. 9.↵
   1. Helal A,
   2. Mikula AL,
   3. Laack NN, et al

   . Myxopapillary ependymomas; proximity to the conus and its effect on presentation and outcomes. Surg Neurol Int 2021;12:429doi:10.25259/SNI_590_2021 pmid:34513192

   CrossRefPubMed
10. 10.↵
    1. Wippold FJ 2nd.,
    2. Smirniotopoulos JG,
    3. Moran CJ, et al

    . MR imaging of myxopapillary ependymoma: findings and value to determine extent of tumor and its relation to intraspinal structures. AJR Am J Roentgenol 1995;165:1263–67 doi:10.2214/ajr.165.5.7572515 pmid:7572515

    CrossRefPubMed
11. 11.↵
    1. Koeller KK,
    2. Shih RY

    . Intradural extramedullary spinal neoplasms: radiologic-pathologic correlation. Radiographics 2019;39:468–90 doi:10.1148/rg.2019180200 pmid:30844353

    CrossRefPubMed
12. 12.↵
    1. Kahan H,
    2. Sklar EM,
    3. Post MJ, et al

    . MR characteristics of histopathologic subtypes of spinal ependymoma. AJNR Am J Neuroradiol 1996;17:143–50 pmid:8770266

    PubMedWeb of Science
13. 13.↵
    1. Friedman DP

    . Presence of superficial siderosis assists in the diagnosis of myxopapillary ependymoma. AJR Am J Roentgenol 1996;166:1493–94 doi:10.2214/ajr.166.6.8633473

    CrossRefPubMed
14. 14.↵
    1. Bertero L,
    2. Ricci AA,
    3. Tampieri C, et al

    . Ependymomas. Pathologica 2022;114:436–46 doi:10.32074/1591-951X-817 pmid:36534422

    CrossRefPubMed
15. 15.↵
    1. Kleinschmidt-DeMasters BK,
    2. Rodríguez FJ,
    3. Tihan T

    . Diagnostic Pathology: Neuropathology. Elsevier 2017:242–49
16. 16.↵
    1. Landriel F,
    2. Ajler P,
    3. Tedesco N, et al

    . Multicentric extramedullary myxopapillary ependymomas: two case reports and literature review. Surg Neurol Int 2012;3:102 doi:10.4103/2152-7806.100859 pmid:23087818

    CrossRefPubMed
17. 17.↵
    1. Vongsfak J,
    2. Jetjumnong C,
    3. Cullen J

    . Image report: extensive disseminated thoracolumbosacral myxopapillary ependymoma. Surg Neurol Int 2020;11:297 doi:10.25259/SNI_390_2020 pmid:33093974

    CrossRefPubMed
18. 18.↵
    1. Almatrafi FR,
    2. Aseeri AM,
    3. Alqahtani MF, et al

    . Myxopapillary ependymoma—a case report of rare multicentric subtype and literature review. Med Arch 2023;77:150–54 doi:10.5455/medarh.2023.77.150-154 pmid:37260799

    CrossRefPubMed
19. 19.↵
    1. Koeller KK,
    2. Rosenblum RS,
    3. Morrison AL

    . Neoplasms of the spinal cord and filum terminale: radiologic-pathologic correlation. Radiographics 2000;20:1721–49 doi:10.1148/radiographics.20.6.g00nv151721 pmid:11112826

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Song C,
    2. Kim HS,
    3. Lee JH, et al

    . Development of a novel prediction model for differential diagnosis between spinal myxopapillary ependymoma and schwannoma. Sci Rep 2024;14:149 doi:10.1038/s41598-023-50806-w

    CrossRefPubMed
21. 21.↵
    1. Choi JY,
    2. Chang KH,
    3. Yu IK, et al

    . Intracranial and spinal ependymomas: review of MR images in 61 patients. Korean J Radiology 2002;3:219–28 doi:10.3348/kjr.2002.3.4.219 pmid:12514338

    CrossRefPubMed
22. 22.↵
    1. Fanous AA,
    2. Jost GF,
    3. Schmidt MH

    . A nonenhancing World Health Organization grade II intramedullary spinal ependymoma in the conus: case illustration and review of imaging characteristics. Global Spine J 2012;2:57–64 doi:10.1055/s-0032-1307260 pmid:24353948

    CrossRefPubMed
23. 23.↵
    1. Kim J,
    2. Kim H,
    3. Kwon H

    . Non-enhancing intradural extramedullary ependymoma: a case report. Taehan Yongsang Uihakhoe Chi 2021;82:1341–45 doi:10.3348/jksr.2020.0147 pmid:36238413

    CrossRefPubMed
24. 24.↵
    1. White JB,
    2. Miller GM,
    3. Layton KF, et al

    . Nonenhancing tumors of the spinal cord. J Neurosurg Spine 2007;7:403–07 doi:10.3171/SPI-07/09/10/403 pmid:17933314

    CrossRefPubMed
25. 25.↵
    1. Graça J,
    2. Gültasli N,
    3. D’Haene N, et al

    . Cystic extramedullary ependymoma. AJNR Am J Neuroradiol 2006;27:818–21 pmid:16611771

    PubMedWeb of Science
26. 26.↵
    1. Tabor JK,
    2. Ryu B,
    3. Schneider D, et al

    . Multifocal lumbar myxopapillary ependymoma presenting with drop metastasis: a case report and review of the literature. Spinal Cord Ser Cases 2022;8:43 doi:10.1038/s41394-022-00513-x pmid:35459220

    CrossRefPubMed
27. 27.↵
    1. Kraetzig T,
    2. McLaughlin L,
    3. Bilsky MH, et al

    . Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management. J Neurosurg Spine 2018;28:201–08 doi:10.3171/2017.5.SPINE161164 pmid:29219779

    CrossRefPubMed
28. 28.↵
    1. Zhang YW,
    2. Wang B,
    3. An SY, et al

    . Clinical management and prognosis of spinal myxopapillary ependymoma: a single-institution cohort of 72 patients. Eur Spine J 2023;32:2459–67 doi:10.1007/s00586-023-07690-9 pmid:37027035

    CrossRefPubMed